Dr. Sadiq was the speaker at journal club this week. He presented the article: "Intravenous gammaglobulin suppresses inflammation through a novel Th2 pathway". The discussion focused on the mechanism of action of IVIg in autoimmune diseases. IVIg, which is a blood product of pooled immunoglobulins, is a treatment for various autoimmune diseases including MS, however it is not FDA approved for the treatment of MS.